P

Inventor

CHWALISZ KRISTOF

US24 patents
⚠️ This page may combine multiple inventors who share the name “CHWALISZ KRISTOF”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHERING AG

14 patents
US5789442AAug 4, 1998

Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents

SCHERING AG135 citations99
US5719136AFeb 17, 1998

Combination of progesterone antagonists and antiestrogens with partial agonistic action for hormone substitution therapy for perimenopausal and postmenopausal women

SCHERING AG114 citations96
US6316432B1Nov 13, 2001

Antigestagenically active steroids with a flourinated 17 α-alkyl chain

SCHERING AG40 citations95
US7148213B2Dec 12, 2006

Antigestagenically active steroids with a fluorinated 17α-alkyl chain

SCHERING AG18 citations92
US6806263B2Oct 19, 2004

Antigestagenically active steroids with a fluorinated 17-alpha-alkyl chain

SCHERING AG17 citations92
US6503895B2Jan 7, 2003

Antigestagenically active steroids with a fluorinated 17α-alkyl chain

SCHERING AG22 citations92
US6225297B1May 1, 2001

Combination contraceptive

SCHERING AG57 citations92
US6028106AFeb 22, 2000

Treatment of urinary incontinence with nitric oxide synthase substrates and/or nitric oxide donors alone or in combination with estrogen or progesterone and/or other agents

SCHERING AG23 citations92
US5906987AMay 25, 1999

Treatment of male climacteric disorders with nitric oxide synthase substrates and/or donors, in combination with androgens and/or aromatase inhibitors

SCHERING AG40 citations92
US6043234AMar 28, 2000

Method for treating endometriosis or leiomyomata uteri with a competitive progesterone antagonist and a gestagen

SCHERING AG25 citations91
US6143754ANov 7, 2000

Competitive progesterone antagonist for demand-oriented female birth control

SCHERING AG14 citations70
US6333350B1Dec 25, 2001

Use of nitric oxide donors and/or substrates or nitric oxide inhibitors for regulating cervical dilatation and extensibility

SCHERING AG3 citations63
US6362237B1Mar 26, 2002

Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception

SCHERING AG5 citations61
US6096732AAug 1, 2000

Steroid esters, process for their production and their pharmaceutical use

SCHERING AG0 citations52

ABBVIE INC

4 patents

UNIV TEXAS

2 patents

MEDICAL RES COUNCIL

1 patent

BAYER SCHERING PHARMA AG

1 patent

EASTERN VIRGINIA MED SCHOOL

1 patent

CHWALISZ KRISTOF

1 patent